Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
about
Stepwise processing analyses of the single-turnover PCSK9 protease reveal its substrate sequence specificity and link clinical genotype to lipid phenotype.Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7
P2860
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
@en
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
@nl
type
label
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
@en
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
@nl
prefLabel
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
@en
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.
@nl
P2093
P2860
P356
P1476
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists
@en
P2093
Andrew Peterson
Cecilia Chiu
Charles Eigenbrot
Daniel J Burdick
John Quinn
Mark Ultsch
Maureen H Beresini
Monica Kong-Beltran
Nicholas J Skelton
Paola Di Lello
P2860
P2888
P304
P356
10.1038/NSMB.3453
P577
2017-08-21T00:00:00Z